PROTOX
LIVE

Serial Number

79414350

Owner

PROTOX Inc.

Attorney

April L. Besl

Filing Date

Dec 3, 2024

Add to watchlist:

No watchlists yet
View on USPTO

PROTOX Trademark

Serial Number: 79414350

PROTOX is a trademark filed by PROTOX Inc. on December 3, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

PROTOX Inc.

94 Jeyakgongdan 4-gil, Hyangnam-eup,

Entity Type: 03

Trademark Details

Filing Date

December 3, 2024

Registration Date

Not Registered

Goods & Services

Wholesale store services featuring pharmaceuticals containing botulinum toxin; retail store services featuring pharmaceuticals containing botulinum toxin; wholesale store services featuring pharmaceutical syringes prefilled with medical botulinum toxin as the main ingredient; retail store services featuring pharmaceutical syringes prefilled with medical botulinum toxin as the main ingredient; wholesale store services featuring drugs for medical purposes; retail store services featuring drugs for medical purposes; wholesale store services featuring pharmaceutical drugs; retail store services featuring pharmaceutical drugs; wholesale store services featuring pre-filled syringes for medical purposes; retail store services featuring pre-filled syringes for medical purposes.

Research and development of vaccines and medicines; biomedical research services; bacteriological research; Botulinum Toxin drug development; inspection of pharmaceuticals; development of pharmaceutical preparations and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; research on the subject of pharmaceuticals; testing, inspection and research services in the fields of pharmaceuticals, cosmetics and foodstuffs, all excluding skin serums and non-medicated skin care preparations; pharmaceutical drug development services

Medical instruments for use in surgery; medical apparatus and instruments for use in surgery; needles for medical purposes; medical apparatus for use in surgery; syringe injectors for medical purposes sold empty; injection needles for medical use; disposable syringes; containers especially adapted for the disposal of syringes; syringes for injections; hypodermic syringes

Pharmaceutical preparations containing botulinum toxin for treating muscle contractions; bacterial poisons; biological preparations for medical or veterinary purposes for the treatment of muscle contractions; pharmaceutical syringes sold prefilled with medical botulinum toxin as the main ingredient; biotechnological preparations for medical purposes for the treatment of muscle contractions; biological preparations for medical purposes for the treatment of muscle contractions; drugs containing botulinum toxin used for medical purposes; pre-filled syringes for medical purposes sold filled with botulinum toxin; pharmaceutical drugs for the treatment of muscle contractions

Beauty therapy, namely, facials, excluding skin serums and non-medicated skin care preparations; medical analysis for the diagnosis and treatment of persons; consulting services in the field of pharmaceutical research; medical and pharmaceutical consultation; remote monitoring of medical data for medical diagnosis and treatment; medical care; medical clinic services; rental of medical apparatus; medical equipment rental; medical information

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 10, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 10, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 10, 2026 TROA
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 25, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 8, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 8, 2026 OPNR
ASSIGNED TO EXAMINER
Jan 29, 2026 DOCK
REFUSAL PROCESSED BY IB
Jan 29, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 10, 2026 RFCS
REFUSAL PROCESSED BY MPU
Jan 10, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 4, 2025 RFCR
NON-FINAL ACTION WRITTEN
Dec 3, 2025 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Dec 2, 2025 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 14, 2025 RFCR
NON-FINAL ACTION WRITTEN
Oct 13, 2025 CNRT
ASSIGNED TO EXAMINER
Sep 6, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 5, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 5, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 9, 2025 REPR